Dupont Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-66,285
| Closed | -$512K | – | 1749 |
|
|
2021
Q1 | $512K | Buy |
+66,285
| New | +$512K | 0.01% | 898 |
|
|
2019
Q4 | – | Sell |
-33,577
| Closed | -$248K | – | 1249 |
|
|
2019
Q3 | $248K | Buy |
+33,577
| New | +$248K | 0.01% | 1051 |
|
|
2018
Q4 | – | Sell |
-15,088
| Closed | -$279K | – | 1175 |
|
|
2018
Q3 | $279K | Hold |
15,088
| – | – | 0.01% | 833 |
|
|
2018
Q2 | $345K | Buy |
+15,088
| New | +$345K | 0.01% | 794 |
|